Zusammenfassung
Hintergrund
Intrahepatische cholangiozelluläre Karzinome (CCC) sind der zweithäufigste primäre epitheliale Lebertumor. Obwohl die Leberresektion die Therapie der Wahl darstellt, liegen bislang nur wenige valide Daten über den Wert dieser Therapieform vor. Wir verfolgen bei dieser Tumorentität einen aggressiven chirurgischen Therapienansatz.
Patienten und Methode
Von 04/1998 bis 06/2004 wurden bei 120 Patienten mit CCC 54 Leberresektionen durchgeführt. Zudem wurden bei 24 Patienten die folgenden 39 Operationserweiterungen vorgenommen: Hepatikusgabelresektion (n=18), Zwerchfellteilresektion (n=6), Gefäßresektion und -rekonstruktion (n=15).
Ergebnisse
Es wurden 30 R0-, 21 R1- und 3 R2-Resektionen erreicht. Nach inkompletter Resektion oder explorativer Laparotomie liegt das mediane Überleben bei 9 bzw. 6 Monaten. Demgegenüber beträgt das mediane Überleben nach R0-Resektion 46 Monate mit 1-/3-/5-Jahres-Überlebensraten von 83%/58%/48%.
Schlussfolgerung
Die Daten zeigen, dass auch beim CCC durch eine R0-Resektion eine signifikante Prognoseverbesserung erreicht werden kann. Die inkomplette Tumorentfernung führt dagegen zu nahezu keiner Verbesserung des Patientenüberlebens. Dies rechtfertigt ein aggressives chirurgisches Vorgehen bei dieser Tumorentität mit dem ausdrücklichen Ziel der RO-Resektion. Die niedrige Resektionsrate von weniger als 50% verdeutlicht die Notwendigkeit für ein verbessertes präoperatives Staging.
Abstract
Background
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy. Tumor resection is the treatment of choice, but so far the value of hepatic resection has not been well defined. We report results with an aggressive surgical approach for the treatment of this tumor entity.
Patients and methods
Between April 1998 and June 2004, 54 liver resections were performed in 120 patients with ICC. In 24 patients, 39 additional procedures were performed: resection of hilar bifurcation (n=18), partial resection of diaphragm (n=6), vascular resection and reconstruction (n=15).
Results
There were 30 R0, 21 R1, and three R2 resections. After R1/R2 resection and explorative laparotomy, the median survival times are 9 months and 6 months, respectively. Following R0 resection, the calculated median survival is 46 months, and the 1-, 3-, and 5-year survival rates are 83%, 58%, and 48%, respectively.
Conclusion
The presented data show that R0 resection leads to a significant prolongation of survival in patients with ICC. In contrast, incomplete tumor removal does not provide a survival benefit. These results justify an aggressive surgical approach to achieve a R0 resection. The low resectability rate of less than 50% underlines the need for improved preoperative staging.
Literatur
Adam R, Bismuth H, Castaing D et al. (1997) Repeat hepatectomy for colorectal liver metastases. Ann Surg 225:51–60
D‘Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP (2003) The role of staging laparoscopy in hepatobiliary malignancy:prospective analysis of 401 cases. Ann Surg Oncol 10: 183
Barbot DJ, Marks JH, Feld RI, Liu JB, Rosato FE (1997) Improving staging of liver tumors using laparoscopic intraoperative ultrasound. J Surg Oncol 64:63
Berdah SV, Delpero JR, Garcia S, Hardwigsen J, Le Treut YP (1996) A western surgical experience of peripheral cholangiocarcinoma. Br J Surg 83:1517
Casavilla FA, Marsh JW, Iwatsuki S et al. (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185:429
Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL (1997) Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 44:760
Chu KM, Lai EC, Al-Hadeedi S et al. (1997) Intrahepatic cholangiocarcinoma. World J Surg 21:301
Hanazaki K, Kajikawa S, Shimozawa N et al. (2002) Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 49:311
Harrison LE, Fong Y, Klimstra DS, Zee SY, Blumgart LH (1998) Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85:1068
Herfarth Ch, Heuschen UA, Lamade W, Lehnert T, Otto G (1995) Rezidivresektionen an der Leber bei primären und sekundären Lebermalignomen. Chirurg 66:949
Inoue K, Makuuchi M, Takayama T et al. (2000) The separate-lesion type cholangiocarcinoma. Surgery 127:498
Itamoto T, Asahara T, Katayama et al. (2001) Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology. Hepatogastroenterology 48:1129
Jarnagin WR, Saldiner PF, Blumgart LH (2000) Cancer of the bile ducts: The hepatic ducts and common bile duct. In: Blumgart LH, Fong Y (eds) Surgery of the liver and biliary tract, 3rd edition. WB Saunders, London Edinburgh New York, S 1017
Kawarada Y, Yamagiwa K, Das BC (2002) Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183:679
Lang H, Radtke A, Liu C, Frühauf NR, Peitgen HO, Broelsch CE (2004) Extended left hepatectomy — modified operation planning based on three-dimensional (3D)-visualization of liver anatomy. Langenbeck’s Arch Surg 389:306
Lang H, Sotiropoulos GC, Dömland M et al. (2005) Extended hepatectomy for intrahepatic Cholangiocellular carcinoma (ICC) — when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-years-period. Ann Surg 241:134
Lang H, Radtke A, Hindennach M Peitgen et al. (2005) Impact of Virtual tumor resection and computer-assisted risk analysis on operation planning and intraoperative strategy in major hepatic resection. Arch Surg 140:629
Lieser MJ, Barry MK, Rowland C, Ilstrup DM, Nagorney DM (1998) Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobil Pancreat Surg 5:41
Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE (1998) Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227:70
Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69:1633
Nakeeb A, Pitt HA, Sohn TA et al. (1996) Cholangiocarcinoma: a spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 224:463
Ohtsuka M, Ito H, Kimura F, Shimizu, Togawa A, Yoshidome H, Miyazaki M (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing the survival. Br J Surg 89:1525
Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353
Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B (1995) Surgical treatment of cholangiocellular carcinoma. World J Surg 19:83
Roayaie S, Guarrera JV, Ye MQ et al. (1998) Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 187:365
Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463
Shimoda M, Farmer DG, Colquhoun SD et al. (2001) Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 7:1023
Sobin LH, Wittekind CH (2002) TNM Classification of malignant tumours. Sixth edition. John Wiley & Sons Ltd, West Sussex
Sotiropoulos GC, Lang H, Broelsch CE (2005) Surgical management of recurrent intrahepatic cholangiocellular carcinoma after liver resection. Surgery 137:669
Taylor-Robinson SD, Toledano M, Arora S et al. (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut 48:816
Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence patterns, and outcomes. J Am Coll Surg 193:384
Weimann A, Varnholt H, Schlitt HJ et al. (2000) Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocarcinoma. Br J Surg 87:182
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lang, H., Sotiropoulos, G.C., Brokalaki, E. et al. Chirurgische Therapie des intrahepatischen cholangiozellulären Karzinoms. Chirurg 77, 53–60 (2006). https://doi.org/10.1007/s00104-005-1069-z
Issue Date:
DOI: https://doi.org/10.1007/s00104-005-1069-z